Premium Reports
Population Health Management 2018, Part 2

Population Health Management 2018, Part 2
Which Vendors Contribute Most to Patient and Financial Outcomes?

Authored by: | Read Time: 4  minutes

Healthcare executives entering into value-based reimbursement (VBR) arrangements do so in an attempt to yield positive financial and patient outcomes. While provider organizations themselves bear some of the responsibility for achieving these outcomes, population health management (PHM) tools also play a crucial role. Yet not all PHM vendors have proven able to consistently contribute to customers’ goals. As a companion to KLAS’ report on PHM vendors’ partnering and guidance, this report examines which vendors are more likely to make a positive impact on customers’ outcomes and how well they perform in three areas highly correlated to customer outcome success: easy-to-use products, clear expectations, and high-quality ongoing training.

Key Findings

  1. HealthEC Biggest Contributor to Financial Success; eClinicalWorks Customers the Most Successful
  2. Customers of athenahealth, Cerner & Epic Report Fewest Financial Outcomes
  3. Contribution Low from Allscripts, GSI Health, & Philips Wellcentive
  4. Consistent Collaboration from Arcadia & Enli Drive High Customer Confidence
  5. HealthEC, Forward Health Group, IBM Watson Health, & SPH Analytics Leverage Training to Improve Physician Usability
  6. HealthEC & Arcadia Drive Strong Outcomes by Delivering Product That Works as Promoted
  7. Actual Product Development Lags behind Expectations Set by athenahealth & Philips Wellcentive
 Download Report Brief  Download Full Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2019 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.